This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moley, J. F. Articles by Brodeur, G. M. Search for Related Content PubMed PubMed Citation Articles by Moley, J. F. Articles by Brodeur, G. M.

Consistent Association of 1p Loss of Heterozygosity with Pheochromocytomas from Patients with Multiple Endocrine Neoplasia Type 2 Syndromes¹

Departments of Surgery [J. F. M., M. B. B., S. A. W.], and Pediatrics [C-T. F., P. S. W., G. M. B.], Washington University School of Medicine, St. Louis, Missouri 63110, and the Department of Oncology [S. B. B., B. N.], Johns Hopkins Oncology Center, Baltimore, Maryland 21231

Pheochromocytomas and medullary thyroid cancers (MTCs) are neuroendocrine tumors which arise sporadically or as part of the multiple endocrine neoplasia type 2 (MEN-2) hereditary syndromes. The most consistent molecular genetic abnormality which has been described in these tumors is loss of heterozygosity (LOH) of the short arm of chromosome 1 (1p). This finding is particularly interesting because the predisposition gene for the hereditary form of these tumors has been mapped to chromosome 10, but LOH on chromosome 10 in MEN-2 tumors is found rarely. We have used a battery of 1p DNA probes to elucidate the region of loss of 1p in 18 pheochromocytomas and 27 MTCs. Using restriction fragment length polymorphism analysis, we identified loss of all or a portion of 1p in 12 of 18 pheochromocytomas. 1p LOH was identified in nine of nine pheochromocytomas in MEN-2A and -2B patients, compared with only two of seven sporadic pheochromocytomas. We also found 1p LOH in one of two von Hippel-Lindau patients. LOH on 1p was noted in only three of 24 informative MTCs, and these were from patients with MEN-2A. In most of the pheochromocytomas, the entire short arm of chromosome 1p appears to have been lost; however, in three of the non-MEN pheochromocytomas and in three MEN-2A MTCs, the region of loss is smaller, allowing estimation of the smallest region of overlap. The combined data for MTCs and pheochromocytomas suggest that the smallest region of overlap of LOH is bounded by D1S15 (1pter-p22) and D1Z2 (1P36.3), excluding a region around MYCL (1p32). Although other regions of 1p should not be completely ruled out, the data suggest that this region may harbor a tumor suppressor gene or genes whose inactivation is important in the development of these tumors. Furthermore, the strong association between 1p LOH and the MEN-2 syndromes, especially in pheochromocytomas, suggests a relationship between the predisposition gene on chromosome 10 and the loss of the suppressor gene on 1p. Alternatively, other loci may be more important in sporadic disease.

¹ This work was supported by a Veterans Administration grant, Research Advisory Group 0001 (J. F. M.), and N. I. H. Grant CA-39771 (G. M. B.).

² To whom requests for reprints should be addressed, at Department of Surgery, Box 8109, Washington University School of Medicine, 4960 Audubon Avenue, St. Louis, MO 63110.

³ Present address: Department of Pediatrics, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642.

Received 8/19/91. Accepted 11/22/91.

This article has been cited by other articles:

				M. Yamakuchi, M. Ferlito, and C. J. Lowenstein miR-34a repression of SIRT1 regulates apoptosis PNAS, September 9, 2008; 105(36): 13421 - 13426. [Abstract] [Full Text] [PDF]

				A. Bagchi and A. A. Mills The Quest for the 1p36 Tumor Suppressor Cancer Res., April 15, 2008; 68(8): 2551 - 2556. [Abstract] [Full Text] [PDF]

				W. Yuan, W. Wang, B. Cui, T. Su, Y. Ge, L. Jiang, W. Zhou, and G. Ning Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immunohistochemistry Endocr. Relat. Cancer, March 1, 2008; 15(1): 343 - 350. [Abstract] [Full Text] [PDF]

				A. Blanes, J. J. Sanchez-Carrillo, and S. J. Diaz-Cano Topographic Molecular Profile of Pheochromocytomas: Role of Somatic Down-Regulation of Mismatch Repair J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1150 - 1158. [Abstract] [Full Text] [PDF]

				D. J. Marsh, G. Theodosopoulos, K. Martin-Schulte, A.-L. Richardson, J. Philips, H.-D. Roher, L. Delbridge, and B. G. Robinson Genome-Wide Copy Number Imbalances Identified in Familial and Sporadic Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1866 - 1872. [Abstract] [Full Text] [PDF]

				C. A. Koch, K. Pacak, and G. P. Chrousos The Molecular Pathogenesis of Hereditary and Sporadic Adrenocortical and Adrenomedullary Tumors J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5367 - 5384. [Abstract] [Full Text] [PDF]

				R. C. T. Aguiar, G. Cox, S. L. Pomeroy, and P. L. M. Dahia Analysis of the SDHD Gene, the Susceptibility Gene for Familial Paraganglioma Syndrome (PGL1), in Pheochromocytomas J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2890 - 2894. [Abstract] [Full Text] [PDF]

				L. Quadro, O. Fattoruso, M. P. Cosma, U. Verga, A. Porcellini, A. Libroia, and V. Colantuoni Loss of Heterozygosity at the RET Protooncogene Locus in a Case of Multiple Endocrine Neoplasia Type 2A J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 239 - 244. [Abstract] [Full Text]

				B. U. Bender, M. Gutsche, S. Gläsker, B. Müller, G. Kirste, C. Eng, and H. P. H. Neumann Differential Genetic Alterations in von Hippel-Lindau Syndrome-Associated and Sporadic Pheochromocytomas J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4568 - 4574. [Abstract] [Full Text]

				D. E. Benn, T. Dwight, A. L. Richardson, L. Delbridge, C. P. Bambach, M. Stowasser, R. D. Gordon, D. J. Marsh, and B. G. Robinson Sporadic and Familial Pheochromocytomas Are Associated with Loss of at Least Two Discrete Intervals on Chromosome 1p Cancer Res., December 1, 2000; 60(24): 7048 - 7051. [Abstract] [Full Text]

				H. Dannenberg, E. J.M. Speel, J. Zhao, P. Saremaslani, E. van der Harst, J. Roth, P. U. Heitz, H. J. Bonjer, W. N.M. Dinjens, W. J. Mooi, et al. Losses of Chromosomes 1p and 3q Are Early Genetic Events in the Development of Sporadic Pheochromocytomas Am. J. Pathol., August 1, 2000; 157(2): 353 - 359. [Abstract] [Full Text] [PDF]

				Y. Murakumo, T. Roth, H. Ishii, D. Rasio, S.-i. Numata, C. M. Croce, and R. Fishel A Human REV7 Homolog That Interacts with the Polymerase zeta Catalytic Subunit hREV3 and the Spindle Assembly Checkpoint Protein hMAD2 J. Biol. Chem., February 11, 2000; 275(6): 4391 - 4397. [Abstract] [Full Text] [PDF]

				E. Edstrom, E. Mahlamaki, B. Nord, M. Kjellman, R. Karhu, A. Hoog, N. Goncharov, B. T. Teh, M. Backdahl, and C. Larsson Comparative Genomic Hybridization Reveals Frequent Losses of Chromosomes 1p and 3q in Pheochromocytomas and Abdominal Paragangliomas, Suggesting a Common Genetic Etiology Am. J. Pathol., February 1, 2000; 156(2): 651 - 659. [Abstract] [Full Text] [PDF]

				S. J. Marx CLINICAL REVIEW 109: Contrasting Paradigms for Hereditary Hyperfunction of Endocrine Cells J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3001 - 3009. [Full Text]

				S. A. Ebrahimi, E. H. Wang, A. Wu, R. R. Schreck, E. Passaro Jr., and M. P. Sawicki Deletion of Chromosome 1 Predicts Prognosis in Pancreatic Endocrine Tumors Cancer Res., January 1, 1999; 59(2): 311 - 315. [Abstract] [Full Text] [PDF]

				H.-K. Lee, Y.-K. Lee, S.-H. Park, Y.-S. Kim, S. H. Park, J. W. Lee, H.-B. Kwon, J. Soh, D. D. Moore, and H.-S. Choi Structure and Expression of the Orphan Nuclear Receptor SHP Gene J. Biol. Chem., June 5, 1998; 273(23): 14398 - 14402. [Abstract] [Full Text] [PDF]